Loading…
Lunai Bioworks Inc. is projected to rise to $3.14 by 2027, a +32% move from its current price of $2.39. LNAI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.26 | $2.39 | $2.53 | +0.02% |
| Aug 6 | $2.20 | $2.39 | $2.59 | +0.04% |
| Aug 7 | $2.17 | $2.39 | $2.64 | +0.05% |
| Aug 8 | $2.13 | $2.39 | $2.68 | +0.07% |
| Aug 9 | $2.10 | $2.39 | $2.72 | +0.09% |
| Aug 10 | $2.08 | $2.39 | $2.75 | +0.11% |
| Aug 11 | $2.06 | $2.39 | $2.79 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.06 | $2.39 | $2.79 | +0.13% |
| Week 2 | $1.93 | $2.40 | $2.97 | +0.25% |
| Week 3 | $1.84 | $2.40 | $3.12 | +0.38% |
| Week 4 | $1.77 | $2.40 | $3.25 | +0.51% |
| Week 5 | $1.71 | $2.41 | $3.38 | +0.64% |
| Week 6 | $1.66 | $2.41 | $3.49 | +0.77% |
| Week 7 | $1.61 | $2.41 | $3.60 | +0.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lunai Bioworks Inc. is a pre-clinical stage biotechnology company that provides medicine, diagnostics, and biodefense products in the United States and the Netherlands.
It operates through three segments, RENB, BioSymetrics, and RENC, and is developing RENB-DC11 to treat solid tumors, primarily pancreatic tumors, as well as RENB-DC20 for breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients.
The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks is headquartered in Los Angeles, California.
Lunai Bioworks Inc. is currently priced at $1.94 with a market capitalization of $8.8M and a market rank of 5120.
Technically, the stock shows a bearish setup with RSI14 at 30, a SMA50 of $2.80, and a SMA200 of $5.07. It sits at support near $1.94 and faces resistance at $4.30. The 30-day trading range runs from $1.33 to $2.83, and annualized volatility stands at 100%.
The year-by-year forecast indicates a neutral stance in 2026 (min $1.47, avg $1.94, max $3.06, ROI 0) and a bullish trajectory from 2027 onward, with rising averages and ROIs through 2050 (for example, 2027 avg $2.56, ROI 31.7%; 2050 avg $6.53, ROI 236.5%).
A major floor 84.7% below — a decisive break under it would weaken the trend.
The nearest floor, 18.8% below — buyers have tended to step in here.
The nearest ceiling, 79.9% above — a clean break opens room to run.
A major ceiling 112.8% above — clearing it would confirm fresh momentum.
Key LNAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LNAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.11 | Buy | $2.11 | Buy |
| MA 10 | $2.32 | Buy | $2.29 | Buy |
| MA 20 | $2.60 | Sell | $2.52 | Sell |
| MA 50 | $2.80 | Sell | $2.76 | Sell |
| MA 100 | $2.74 | Sell | $3.50 | Sell |
| MA 200 | $5.07 | Sell | $8.31 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.28 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -146.12 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | -34.90 | Sell |
| Bollinger %B (20,2) | 0.02 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.78 | Sell |
| Awesome (5,34) | -0.80 | Sell |
| Ultimate (7,14,28) | 10.62 | Buy |
| Momentum (10) | -0.88 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 1.95 | Buy |
| ADX (14) | 18.11 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is bearish, with RSI14 at 30. The SMA50 is $2.80 while the SMA200 is $5.07, indicating a bearish tilt in the near term.
The price of $1.94 sits at the stated support level of $1.94 and faces resistance at $4.30. The 30-day range is $1.33 to $2.83, illustrating a narrow near-term trading band.
An annualized volatility of 100% underscores the high level of near-term price fluctuation for this asset.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.47 | $2.39 | $3.77 | 0% | Neutral | |
| $2.29 | $3.14 | $4.66 | +32% | Bullish | |
| $2.44 | $3.57 | $5.65 | +49% | Bullish | |
| $2.37 | $3.65 | $6.06 | +53% | Bullish | |
| $1.85 | $2.98 | $5.16 | +25% | Bullish | |
| $1.86 | $3.14 | $5.63 | +31% | Bullish | |
| $1.68 | $2.95 | $5.46 | +24% | Bullish | |
| $1.76 | $3.23 | $6.14 | +35% | Bullish | |
| $2.52 | $4.80 | $9.35 | +101% | Bullish | |
| $2.32 | $4.60 | $9.17 | +92% | Bullish | |
| $2.61 | $5.80 | $12.73 | +143% | Bullish | |
| $3.62 | $8.04 | $18.48 | +236% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.47 | $2.39 | $3.11 | +0.00% |
| September 2026 | $2.00 | $2.43 | $3.08 | +1.76% |
| October 2026 | $1.97 | $2.43 | $3.14 | -0.09% |
| November 2026 | $2.17 | $2.70 | $3.55 | +11.23% |
| December 2026 | $2.24 | $2.83 | $3.77 | +4.62% |
Click any year to see its month-by-month LNAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, LNAI is projected to trade between $1.47 and $3.77, averaging $2.39 — a potential gain of 0% from today's $2.39. A consolidation phase looks the most probable path here.
Lunai Bioworks Inc.'s 2027 outlook centres on $3.14, within a $2.29 to $4.66 range. That is up +32% on the projected 2026 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2028, LNAI could reach as high as $5.65, with a base case around $3.57 and support toward $2.44 — roughly +49% from $2.39. Buyers look set to stay in control over this stretch.
Expect LNAI to range from $2.37 to $6.06 through 2029. The $3.65 average target implies a +53% move from current prices. That is up +2% on the projected 2028 average. Momentum favours further upside here.
The LNAI price prediction for 2030 points to an average of $2.98 (low $1.85, high $5.16) — a potential gain of +25% on today's $2.39. Buyers look set to stay in control over this stretch.
In 2031, LNAI is projected to trade between $1.86 and $5.63, averaging $3.14 — a potential gain of +31% from today's $2.39. That is up +6% on the projected 2030 average. Momentum favours further upside here.
Lunai Bioworks Inc.'s 2032 outlook centres on $2.95, within a $1.68 to $5.46 range. That is -6% versus the projected 2031 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, LNAI could reach as high as $6.14, with a base case around $3.23 and support toward $1.76 — roughly +35% from $2.39. Momentum favours further upside here.
Expect LNAI to range from $2.52 to $9.35 through 2034. The $4.80 average target implies a +101% move from current prices. That is up +48% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The LNAI price prediction for 2035 points to an average of $4.60 (low $2.32, high $9.17) — a potential gain of +92% on today's $2.39. Momentum favours further upside here.
In 2040, LNAI is projected to trade between $2.61 and $12.73, averaging $5.80 — a potential gain of +143% from today's $2.39. That is up +26% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Lunai Bioworks Inc.'s 2050 outlook centres on $8.04, within a $3.62 to $18.48 range. That is up +38% on the projected 2040 average. That marks a +236% change versus current levels. Momentum favours further upside here.
Investing $1,000 in LNAI today (≈ 418.410042 LNAI) could be worth
$3,362.54
+$2,362.54 (+236%) by 2050 · US Dollar
Based on the average projected LNAI price of $8.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LNAIwould be worth at today's price.
$1,000 invested in LNAI on Jul 31, 2025 (≈ 48.923678 LNAI) would be worth
$116.93
-$883.07 (-88.3%) today · 0.12× · US Dollar
Based on a LNAI entry price of $20.44 vs. today's $2.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.33 | $1,025.75 | +2.6% |
| 1 month ago | $3.09 | $773.46 | -22.7% |
| 3 months ago | $2.56 | $933.89 | -6.6% |
| 6 months ago | $6.06 | $394.39 | -60.6% |
| 1 year ago | $20.44 | $116.93 | -88.3% |
| All time (5.0y) ago | $442.4 | $5.4 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LNAI forecast.
Our base-case forecast reaches $4.80 around 2040.
Implied market cap at $4.80: $21.76M
The multi-year forecast shows a bullish trajectory after a neutral start in 2026, with the average price rising across the years and ROIs turning positive.
By 2027, the average price is expected to be $2.56 with a 31.7% ROI, continuing the bullish trend into subsequent years. The forecast projects a 2028 average of $2.90 and a 49.7% ROI, followed by a 2029 average of $2.96 and a 52.8% ROI, then a 2030 average of $2.42 with a 24.8% ROI.
Longer term, the forecast shows higher price levels and sizable ROIs: 2034 average $3.91 with 101.8% ROI, 2035 average $3.74 with 92.7% ROI, 2040 average $4.74 with 144.1% ROI, and 2050 average $6.53 with 236.5% ROI (max prices rising to $10.39 in 2040 and $15.02 in 2050).
These are estimates and not guarantees; actual results may differ, and the long-run path depends on factors not captured here.
Tap a question to reveal the answer.
The forecast gives an average price of $2.42 with a minimum of $1.50 and a maximum of $4.19, corresponding to a ROI of 24.8% and a bullish sentiment.
The 2026 forecast is neutral with an average price of $1.94 and ROI of 0%. From 2027 onward, the forecast is bullish with rising averages and ROIs (e.g., 2027 avg $2.56, ROI 31.7%; 2050 avg $6.53, ROI 236.5%), but these are estimates and not guarantees.
Yes. The 2040 forecast shows a maximum price of $10.39, with an average of $4.74 and ROI of 144.1%, while the 2034–2050 path includes higher maximums (2050 max $15.02). These figures are projections and not guaranteed.
$1.33 to $2.83.
Lunai Bioworks Inc. Community Discussion
0Share your Lunai Bioworks Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.